CJC No DAC + Ipamorelin combination
Get CJC No DAC + Ipamorelin combinationThe classic GH-axis pairing: CJC-1295 without DAC (the shorter-acting form, also called Mod GRF 1-29) with ipamorelin. Sold as one bundle; each component's research is on its own page.
Composition
What's in CJC No DAC + Ipamorelin combination?
CJC No DAC + Ipamorelin combination is a blend — it combines these research peptides, sold together as one item:
- CJC-1295· 5mg per bottle; 50mcg per spray· GHRH analog stimulating pituitary somatotrophs via cAMP cascade
- Ipamorelin· 5mg per bottle; 50mcg per spray· Selective ghrelin mimetic at GHS-R1a receptor
The evidence
What the research says about each peptide in CJC No DAC + Ipamorelin combination
A blend is only as studied as its parts. The reported findings below come from each peptide’s own research — grouped by compound so you always know which one a finding belongs to, and every claim links to the source it came from.
CJC-1295
8 sourced studiesGHRH analog stimulating pituitary somatotrophs via cAMP cascade
- Cardioprotective effects 60/100Rated 60/100Source typeSpecialist communityIndependent sources2Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Visceral adipose tissue reduction 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Treatment of HIV-associated lipodystrophy 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Sexual arousal and desire modulation via CNS 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Diagnosis of adult growth hormone deficiency 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Treatment of diabetic gastroparesis 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
Reported routines
- CJC-1295: 50-100 mcg; Ipamorelin: 100-200 mcg 60/100Rated 60/100Source typeSpecialist communityIndependent sources7Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
Ipamorelin
8 sourced studiesSelective ghrelin mimetic at GHS-R1a receptor
- Dose-proportional stimulation of growth hormone release across a range of infusion doses 92/100Rated 92/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Short terminal half-life (~2 hours) and dose-proportional pharmacokinetics 92/100Rated 92/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Selective growth hormone secretagogue activity (first selective GH secretagogue) 88/100Rated 88/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Stimulation of natural growth hormone release 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Enhanced lipolysis and fat metabolism 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Improved muscle protein synthesis and recovery 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
Reported routines
- 100–250 mcg once daily SC (research: 100–300 mcg 2–3×/day) 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
Free: The Peptide Stack Cheat-Sheet
See where CJC No DAC + Ipamorelin combination fits — the most-used combinations, dosing notes from the research, and what to check before you buy.
No spam. Unsubscribe anytime.
Get CJC No DAC + Ipamorelin combination
Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.
Wondering how CJC No DAC + Ipamorelin combination pricing compares across suppliers? Our original market data shows the full picture.
See the State of the Peptide Market 2026 →